Dr. Diana Buist explains the new Breast Cancer Surveillance Consortium study in JAMA Oncology, which she co-wrote.
Based on a new BCSC study, Dr. Diana Buist tells of technology that adds cost to breast cancer screening—without improving outcomes. Dr. Marc Mora comments.
CAD raises screening costs without benefit to patients and may miss cancers, large national BCSC study shows.
A Breast Cancer Surveillance Consortium study involving Group Health shows that density shouldn’t be the only factor when considering additional screening.
An online tool and app to estimate breast cancer risk is a conversation starter for women and practitioners.
Here’s our list of top-ten research stories of 2014—plus links to the news reports they inspired.
Dense breasts are a risk factor for breast cancer, and the more dense breasts are, the more difficult it can be to detect cancer on mammograms. Many state regulations have been enacted—and more proposed—requiring health providers to tell women if their mammogram shows their breasts are dense.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.